1. Anderson RR, Parrish JA: Selective photothermolysis: Precise microsurgery by selective absorption of pulsed radiation. Science 220:524-527, 1983
2. Bjerring P: Clinical comparison of hair reduction using the newest generation IPL and a first generation ruby laser. J Cutan Laser Ther 2:211, 2000
3. Raulin C et al: Treatment of port-wine stains with a noncoherent pulsed light source. A retrospective study. Arch Dermatol 135:679-683, 1999
4. Einstein A: Zur Quantentheorie der Strahlung. Physikalische Zeitschrift 18:121-128, 1917
5. Kimel S et al: Vascular response to laser photothermolysis as a function of pulse duration, vessel type, and diameter: Implications for port wine stain laser therapy. Lasers Surg Med 30:160-169, 2002
6. Babilas P et al: Selective photothermolysis of blood vessels following flashlamp-pumped pulsed dye laser irradiation: In vivo results and mathematical modelling are in agreement. J Invest Dermatol 125:343-352, 2005
7. Bäumler W et al: The effects of intense pulsed light (IPL) on blood vessels investigated by mathematical modeling. Lasers Surg Med 39:132-139, 2007
8. Shafirstein G et al: A new mathematical approach to the diffusion approximation theory for selective photothermolysis modeling and its implication in laser treatment of port-wine stains. Lasers Surg Med 34:335-347, 2004
9. Goldberg DJ: Laser- and light-based hair removal: an update. Expert Rev Med Devices 4:253-260, 2007
10. Jia W et al: Improvement of port wine stain laser therapy by skin preheating prior to cryogen spray cooling: a numerical simulation. Lasers Surg Med 38:155-162, 2006
11. Raulin C, Greve B: IPL technology: A review. Lasers Surg Med 32:78-87, 2003
12. Bäumler W et al: Optimal parameters for the treatment of leg veins using Nd:YAG lasers at 1064 nm. Br J Dermatol 155:364-371, 2006
13. Laubach H et al: Effects of skin temperature on lesion size in fractional photothermolysis. Lasers Surg Med 39:14-18, 2007
14. Fuchs B et al: Techniques for endoscopic and non-endoscopic intracorporeal laser applications. Endosc Surg Allied Technol 1:217-223, 1993
15. Bäumler W Et al: The effect of different spot sizes on the efficacy of hair removal using a long-pulsed diode laser. Dermatol Surg 28:118-121, 2002
16. Goldman L: Progress in laser safety in biomedical installations. Arch Environ Health 20:193-196, 1970
17. Powell C, Goldman L: Recommendations of the Laser Safety Conference. Arch Environ Health 18:448-452, 1969
18. Anderson RR: What is safe? An introduction. Lasers Surg Med 39:7, 2007
19. Greve B, Raulin C: Professional errors caused by lasers and Intense Pulsed Light technology in dermatology and aesthetic medicine: Preventive strategies and case studies. Dermatol Surg 28:156-161, 2002
20. Goldman L et al: Effect of the laser beam on the skin. Preliminary report. J Invest Dermatol 40:121-122, 1963
21. Lorenz S et al: Hautveränderungen bei Neugeborenen in den ersten 5 Lebenstagen. Hautarzt 51:396-400, 2000
22. Osburn K, Schosser RH, Evert MA: Congenital pigmented and vascular lesions in newborn infants. J Am Acad Dermatol 16:788-792, 1987
23. Rivers JK, Fredericksen PC, Dibolin C: A prevalence survey of dermatoses in the australian neonate. J Am Acad Dermatol 23:77-81, 1990
24. Rosen S, Smoller BR: Port-wine stains: A new hypothesis. J Am Acad Dermatol 17:164-166, 1987
25. Rydh M et al: Ectatic blood vessels in port-wine stains lack innervation: Possible role in pathogenesis. Plast Reconstr Surg 87:419-422, 1991
26. Smoller BR, Rosen S: Portwine stains: A disease of altered neural modulation of blood vessels? Arch Dermatol 122:177-179, 1986
27. Sanchez-Carpintero I et al: Epithelial and mesenchymal hamartomatous changes in a mature port-wine stain: Morphologic evidence for a multiple germ layer field defect. J Am Acad Dermatol 50:608-612, 2004
28. Revencu N et al: Parkes Weber syndrome, Vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Human Mutation 29:959-965, 2008
29. Boon LM et al: variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev 15:265-269, 2005
30. Hershkovitz D et al: RASA1 mutations may cause hereditary capillary malformations without arteriovenous malformations. Br J Dermatol 158:1035-1040, 2008
31. Vural E et al: The expression of vascular endothelial growth factor and its receptors in port-wine stains. Otolaryngol Head Neck Surg 139:560-564, 2008
32. Scherer K et al: Both the flashlamp-pumped dye laser and the long-pulsed tunable dye laser can improve results in port-wine stain therapy. Br J Dermatol 145:79-84, 2001
33. Geronemus RG et al: High-fluence modified pulsed dye laser photocoagulation with dynamic cooling of port-wine stains in infancy. Arch Dermatol 136:942-943, 2000
34. Edström DW, Ros AM: The treatment of port-wine stains with the pulsed dye laser at 600 nm. Br J Dermatol 136:360-363, 1997
35. Galeckas KJ: Update on lasers and light devices for the treatment of vascular lesions. Semin Cutan Med Surg 27;276-284, 2008
36. Stier MF, Glick SA, Hirsch RJ: Laser treatment of pediatric vascular lesions: Port wine stains and hemangiomas. J Am Acad Dermatol 58:261-285, 2008
37. Reyes BA, Geronemus RG: Treatment of port-wine stains during childhood with the flashlamp-pumped pulsed dye laser. J Am Acad Dermatol 23:1142-1148, 1990
38. Van der Horst CM et al: Effect of the timing of treatment of port-wine stains with the flash-lamp-pumped pulsed dye laser. N Engl J Med 338:1028-1033, 1998
39. Renfro L, Geronemus RG: Anatomical differences of port-wine stains in response to treatment with the pulsed dye laser. Arch Dermatol 129:182-188, 1993
40. Kane KS et al: Pulsed dye laser-resistant port-wine stains. Arch Dermatol 132:839-841, 1996
41. Katugampola GA, Lanigan SW: Laser treatment of port-wine stains: Therapeutic outcome in relation to morphological parameters. Br J Dermatol 136:467-468, 1997
42. Namba Y, Mae O, Ao M: The treatment of port wine stains with a dye laser: A study of 644 patients. Scand J Plast Reconstr Hand Surg 35:197-202, 2001
43. Nguyen CM et al: Facial port wine stains in childhood: prediction of the rate of improvement as a function of the age of the patient, size and location of the port wine stain and the number of treatments with the pulsed dye (585 nm) laser. Br J Dermatol 138:821-825, 1998
44. Wlotzke U et al: Side-effects and complications of flashlamp-pumped pulsed dye laser therapy of port-wine stains. A prospective study. Br J Dermatol 134:475-480, 1996
45. Seukeran DC, Collins P, Sheehan-Dare RA: Adverse reactions following pulsed tunable dye laser treatment of port wine stains in 701 patients. Br J Dermatol 136:725-729, 1997
46. Levine VJ, Geronemus RG: Adverse effects associated with the 577- and 585-nanometer pulsed dye laser in the treatment of cutaneous vascular lesions: A study of 500 patients. J Am Acad Dermatol 32:613-617, 1995
47. Bernstein LJ, Geronemus RG: Keloid formation with the 585-nm pulsed dye laser during
isotretinoin treatment.
Arch Dermatol 133:111-112, 1997
48. Michel S, Landthaler M, Hohenleutner U: Recurrence of port-wine stains after treatment with the flashlamp-pumped pulsed dye laser. Br J Dermatol 143:1230-1234, 2000
49. Huikeshoven M et al: Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment. N Engl J Med 356:1235-1240, 2007
50. Orten SS et al: Port wine stains. An assessment of 5 years of treatment. Arch Otolaryngol Head Neck Surg 122:1174-1179, 1996
51. Galeckas KJ, Ross EV, Uebelhoer NS. A pulsed dye laser with a 10-mm beam diameter and a pigmented lesion window for purpura-free photorejuvenation. Dermatol Surg 34:308-313, 2008
52. Jasim ZF, Handley JM: Treatment of pulsed dye laser-resistant port wine stain birthmarks. J Am Acad Dermatol 57:677-682, 2007
53. Izikson L, Anderson RR: Treatment endpoints for resistant port wine stains with a 755 nm laser. J Cosmet Laser Ther 11:52-55, 2009
54. Yang MU et al: Long-pulsed neodymium:yttrium-aluminum-garnet laser treatment for port-wine stains. J Am Acad Dermatol 52:480-490, 2005
55. McGill DJ, MacLaren W, Mackay IR: A direct comparison of pulsed dye, alexandrite, KTP and Nd:YAG lasers and IPL in patients with previously treated capillary malformations. Lasers Surg Med 40:390-398, 2008
56. Lorenz S et al: Variable pulse frequency-doubled Nd:YAG laser versus flashlamp-pumped pulsed dye laser in the treatment of port wine stains. Acta Derm Venereol 83:210-213, 2003
57. Strempel H, Klein W: Laser therapy without laser: A controlled trial comparing the flashlamp-pumped dye laser with the Photoderm high-energy gas discharge lamp. Lasers Med Sci 11:185-187, 1996
58. Bjerring P, Christiansen K, Troilius A: Intense pulsed light source for the treatment of dye laser resistant port-wine stains. J Cosmet Laser Ther 5:7-13, 2003
59. Faurschou A et al: Pulsed dye laser vs. intense pulsed light for port-wine stains: A randomized side-by-side trial with blinded response evaluation. Br J Dermatol 160;359-364, 2009
60. Babilas P et al: Split-face comparison of intense pulsed light with the flashlamp-pumped pulsed dye laser and the long-pulsed tunable dye laser fort he treatment of port-wine stains: a comparative study. Lasers [Archana2]Surg Med 42(8):720-727, 2010
61. Ashinoff RA, Geronemus RG: Capillary hemangiomas and treatment with the flash lamp-pumped pulsed dye laser. Arch Dermatol 127:202-205, 1991
62. Hohenleutner S et al: Long-term results in the treatment of childhood hemangioma with the flashlamp-pumped pulsed dye laser: An evaluation of 617 cases. Lasers Surg Med 28:273-277, 2001
63. Landthaler M, Hohenleutner U, Abd-El Raheem TA: Laser therapy of childhood hemangiomas. Br J Dermatol 133:275-281, 1995
64. Rizzo C et al: Outcomes of childhood hemangiomas treated with the pulsed-dye laser with dynamic cooling: A retrospective chart analysis. Dermatol Surg 35:1947-1954, 2009
65. Morelli JG, Tan OT, Weston WL: Treatment of ulcerated hemangiomas with the pulsed tunable dye laser. Am J Dis Child 145:1062-1064, 1991
66. Poetke M, Philipp C, Berlien HP: Flashlamp-pumped pulsed dye laser for hemangiomas in infancy: Treatment of superficial vs. mixed hemangiomas. Arch Dermatol 136:628-632, 2000
67. Batta K et al: Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood hemangiomas: Results of a 1-year analysis. Lancet 360:521-527, 2002
68. Kono T et al: Comparison study of traditional dye and long-pulsed dye laser in the treatment of early haemangiomas. Lasers Surg Med S17:36, 2005
69. Leaute-Labreze C et al:
Propranolol for severe hemangiomas of infancy.
N Engl J Med 358:2649-2651, 2008
70. Sans V et al:
Propranolol for severe infantile hemangiomas: Follow-up report.
Pediatrics 124: e423-e431, 2009
71. Rohrer TE et al: Does pulse stacking improve the results of treatment with variable-pulse pulsed-dye lasers? Dermatol Surg 30:163-167, 2004
72. Nymann P, Hedelund L, Haedersdal M: Long-pulsed dye laser vs. intense pulsed light for the treatment of facial telangiectasias: A randomized controlled trial. J Eur Acad Dermatol Venereol 24:143-146, 2010
73. Adrian RM, Tanghetti EA: Long pulse 532-nm laser treatment of facial telangiectasia. Dermatol Surg 24:71-74, 1998
74. Goldberg DJ, Meine JG: A comparison of four frequency-doubled Nd:YAG (532 nm) laser systems for treatment of facial telangiectases. Dermatol Surg 25:463-467, 1999
75. Tierney E, Hanke CW: Randomized controlled trial: Comparative efficacy for the treatment of facial telangiectasias with 532 nm versus 940 nm diode laser. Lasers Surg Med 41:555-562, 2009
76. Sarradet DM, Hussain M, Goldberg DJ: Millisecond 1064-nm Neodymium:YAG laser treatment of facial telangiectases. Dermatol Surg 29:56-58, 2003
77. Groot D et al: Algorithm for using a long-pulsed Nd:YAG laser in the treatment of deep cutaneous vascular lesions. Dermatol Surg 29:35-42, 2003
78. Eremia S, Li CY: Treatment of face veins with a cryogen spray variable pulse width 1064 nm Nd:YAG laser: A prospective study of 17 patients. Dermatol Surg 28:244-247, 2002
79. Wenzel SM, Hohenleutner U, Landthaler M: Progressive disseminated essential telangiectasia and erythrosis interfollicularis colli as examples for successful treatment with a high-intensity flashlamp. Dermatology 217:286-290, 2008
80. Hohenleutner U et al: Behandlung von Besenreisern mit einem blitzlampengepumpten gepulsten Farbstofflaser mit 1,5 ms Impulsdauer. Hautarzt 49:560-565, 1998
81. Hohenleutner U et al: Leg Telangiectasia treatment with a 1.5 ms pulsed dye laser,
ice cube cooling of the skin and 595 vs. 600 nm: Preliminary results.
Lasers Surg Med 23:72-78, 1998
82. Kauvar AN, Lou WW: Pulsed alexandrite laser for the treatment of leg telangiectasia and reticular veins. Arch Dermatol 136:1371-1375, 2000
83. Eremia S, Li C, Umar SH: A side-by-side comparative study of 1064 nm Nd:YAG, 810 nm diode and 755 nm Alexandrite lasers for treatment of 0,3-3 mm leg veins. Dermatol Surg 28:224-230, 2002
84. Kaudewitz P, Klövekorn W, Rother W: Effective treatment of leg vein telangiectasia with a new 940 nm diode laser. Dermatol Surg 27:101-106, 2001
85. Kaudewitz P, Klövekorn W, Rother W: Treatment of leg vein telangiectases: 1-year results with a new 940 nm diode laser. Dermatol Surg 28:1031-1034, 2002
86. Mordon S, Brisot D, Fournier N: Using a “non uniform pulse sequence” can improve selective coagulation with a Nd:YAG laser (1.06 μm) thanks to Met-Hemoglobin absorption: A clinical study on blue leg veins. Lasers Surg Med 32:160-170, 2003
87. Omura NE et al: Treatment of reticular leg veins with a 1064 nm long-pulsed Nd:YAG laser. J Am Acad Dermatol 48:76-81, 2003
88. Rogachewsky AS, Silapunt S, Goldberg DJ: Nd:YAG laser (1064 nm) irradiation for lower extremity telangiectases and small reticular veins: Efficacy as measured by vessel color and size. Dermatol Surg 28:220-223, 2002
89. Coles CM, Werner RS, Zelickson BD: Comparative pilot study evaluating the treatment of leg veins with a long pulse Nd:YAG laser and sclerotherapy. Lasers Surg Med 30:154-159, 2002
90. Levy JL et al: Comparison and sequential study of long pulsed Nd:YAG 1064 nm laser and sclerotherapy in leg telangiectasias treatment. Lasers Surg Med 34:273-276, 2004
91. Lupton JR, Alster TS, Romero P: Clinical comparison of sclerotherapy versus long-pulsed Nd:YAG laser treatment for lower extremity telangiectases. Dermatol Surg 28:694-697, 2002
92. Lurie F et al: Prospective randomized study of endovenous radiofrequency obliteration (closure procedure) versus ligation and stripping in a selected patient population (EVOLVeS Study). J Vasc Surg 38:207-214, 2003
93. Lurie F et al: Prospective randomised study of endovenous radiofrequency obliteration (closure) versus ligation and vein stripping (EVOLVeS): Two-year follow-up. Eur J Vasc Endovasc Surg 29:67-73, 2005
94. Proebstle TM et al: Infrequent early recanalization of greater saphenous vein after endovenous laser treatment. J Vasc Surg 38:511-516, 2003
95. Van den Bos R et al: Endovenous therapies of lower extremity varicosities: A meta-analysis. J Vasc Surg 49:230-239, 2009
96. Bailin PL, Kantor GR, Wheeland RG: Carbon dioxide laser vaporization of lymphangioma circumscriptum. J Am Acad Dermatol 14:257-262, 1986
97. Eliezri YD, Sklar JA: Lymphangioma circumscriptum: review and evaluation of carbon dioxide laser vaporization. J Dermatol Surg Oncol 14:357-364, 1988
98. Huilgol SC, Neill S, Barlow RJ: CO2 laser therapy of vulval lymphangiectasia and lymphangioma circumscriptum. Dermatol Surg 28:575-577, 2002
99. Landthaler M, Hohenleutner U, Braun-Falco O: Acquired lymphangioma of the vulva: Palliative treatment by means of carbon dioxide laser vaporization. Arch Dermatol 126:967-968, 1990
100. Roncero M et al: Multiwavelength laser treatment of venous lakes. Dermatol Surg 35:1942-1946, 2009
101. Landthaler M et al: Effects of argon, dye and Nd:YAG lasers on epidermis, dermis, and venous vessels. Lasers Surg Med 6:87-93, 1986
102. Lim RY: Nd:YAG laser surgery of venous malformations. W V Med J 89:109-110, 1993
103. Werner JA et al: Ultrasound-guided interstitial Nd: YAG laser treatment of voluminous hemangiomas and vascular malformations in 92 patients. Laryngoscope 108:463-470, 1998
104. Werner JA et al: YAG laser therapy of voluminous hemangiomas and vascular malformations. Adv Otorhinolaryngol 49:75-80, 1995
105. Michel JL et al: CO2, Er:YAG and pulsed dye laser treatment of angiofibromas in patients with tuberous sclerosis. Med Laser Appl 19:136-145, 2004
106. Tope WD et al: “Hot” KTP-laser treatment of facial angiofibromata. Lasers Surg Med 29:78-81, 2001
107. Boixeda P et al: CO2, argon, and pulsed dye laser treatment of angiofibromas. J Dermatol Surg Oncol 20:808-812, 1994
108. Janniger CK, Goldberg DJ: Angiofibromas in tuberous sclerosis: Comparison of treatment by carbon dioxide and argon laser. J Dermatol Surg Oncol 16:317-320, 1990
109. Weston J et al: Carbon dioxide laserabrasion for treatment of adenoma sebaceum in tuberous sclerosis. Ann Plast Surg 15:132-137, 1985
110. Papadavid E et al: Carbon dioxide and pulsed dye laser treatment of angiofibromas in 29 patients with tuberous sclerosis. Br J Dermatol 147:337-342, 2002
111. Collyer J et al: Comparison of treatment of cherry angiomata with pulsed-dye laser, potassium titanyl phosphate laser, and electrodesiccation: a randomized controlled trial. Arch Dermatol 146:33-37, 2010
112. Werner A et al: Hereditary haemorrhagic telangiectasia treated by pulsed neodymium:yttrium-aluminium-garnet (Nd:YAG) laser (1,064 nm). Lasers Med Sci 23:385-391, 2008
113. Long CC, Lanigan SW: Treatment of angioma serpiginosum using a pulsed tunable dye laser. Br J Dermatol 136:631-632, 1997
114. Berger C, Kopera D: KTP-Laser-Koagulation bei Xanthelasma palpebrarum. J Dtsch Dermatol Ges 3:775-779, 2005
115. Borelli C, Kaudewitz P: Xanthelasma palpebrarum: Treatment with the Erbium:YAG laser. Lasers Surg Med 29:260-264, 2001
116. Drnovšek-Olup B, Vedlin B: Use of Er:YAG laser for benign skin disorders. Lasers Surg Med 21:13-19, 1997
117. Wheeland RG, Bailin PL, Kronberg E: Carbon dioxide (CO2) Laser vaporization for the treatment of multiple trichoepitheliomata. J Dermatol Surg Oncol 10:470-475, 1984
118. Sawchuck WS, Heald PW: CO2 laser treatment of trichoepithelioma with focused and defocused beam. J Dermatol Surg Oncol 10:905-907, 1984
119. Rallan D, Harland CC: Brooke-Spiegler syndrome: Treatment with laser ablation. Clin Exp Dermatol 30:355-357, 2005
120. Algermissen B et al: CO2 laser treatment of neurofibromas of patients with neurofibromatosis type 1: Five years experience. Med Laser Appl 16:265-274, 2001
121. Krähenbühl A, Eichmann A, Pfaltz M: CO2 Laser therapy for steatocystoma multiplex. Dermatologica 183:294-296, 1991
122. Karrer S et al: Treatment of digital mucous cysts with a carbon dioxide laser. Acta Derm Venereol (Stockh) 79:224-225, 1999
123. Hohenleutner U, Landthaler M: Laser therapy of verrucous epidermal naevi. Clin Exp Dermatol 18:124-127, 1993
124. Boyce S, Alster T: CO2-laser treatment of epidermal nevi: long-term success. Dermatol Surg 28:611-614, 2002
125. Alam M, Arndt KA: A method for pulsed carbon dioxide laser treatment of epidermal nevi. J Am Acad Dermatol 46:554-556, 2002
126. Park J-H et al: YAG laser treatment of verrucous epidermal nevi. Dermatol Surg 30:378-381, 2004
127. Pearson IC, Harland CC: Epidermal naevi treated with pulsed erbium:YAG laser. Clin Exp Dermatol 29:494-496, 2004
128. Sidwell RU, Syed S, Harper JI: Pulsed dye laser treatment for inflammatory linear verrucous epidermal nevus. Br J Dermatol 144;1267-1269, 2001
129. Tschanz Cet al: Vulvodynia after CO2 laser treatment of the female genital mucosa. Dermatology 202:371-372, 2001
130. Garden JM et al: Papillomavirus in the smoke of carbon-dioxide laser treated verrucae. J Am Med Assoc 259:1199-1202, 1988
131. Landthaler M et al: Laser therapy of bowenoid papulosis and Bowen's disease. J Dermatol Surg Oncol 12:1253-1257, 1986
132. Landthaler M et al: Behandlung mit dem Neodym-YAG-Laser. Münch Med Wschr 129:424-425, 1987
133. Duus BR et al: Refractory condylomata acuminata: A controlled clinical trial of carbon-dioxide laser versus conventional surgical treatment. Genitourin Med 61:59-61, 1985
134. Ferenczy A: Comparison of 5-fluorouracil and CO2-laser for treatment of vaginal condylomata. Obstet Gynecol 64:773-778, 1984
135. Läuchli S et al: CO2 laser treatment of warts in immunosuppressed patients. Dermatology 206:148-152, 2003
136. Wollina U, Konrad H, Karamfilov T: Treatment of common warts and actinic keratoses by Er:YAG laser. J Cutan Laser Ther 3:63-66, 2001
137. Street ML, Roenigk RK: Recalcitrant periungual verrucae: The role of carbon dioxide laser vaporization. J Am Acad Dermatol 23:115-120, 1990
138. Kopera D: Verrucae vulgares: Flashlamp-pumped pulsed dye laser treatment in 134 patients. Int J Dermatol 42:905-908, 2003
139. Wu C et al: Efficacy of pulsed-dye laser for viral warts - An internal audit. Ir Med J 96:82-83, 2003
140. Vargas H et al: The treatment of facial verrucae with the pulsed dye laser. Laryngoscope 112:1573-1576, 2002
141. Hughes PSH: Treatment of molluscum contagiosum with the 585-nm pulsed dye laser. Dermatol Surg 24:229-230, 1998
142. Hammes S, Greve B, Raulin C: Mollusca contagiosa. Behandlung durch gepulsten Farbstofflaser. Hautarzt 52:38-42, 2003
143. Michel JL: Treatment of molluscum contagiosum with 585 nm
collagen remodeling pulsed dye laser.
Eur J Dermatol 14:103-106, 2004
144. Kartamaa M, Reitamo S: Treatment of lichen sclerosus with carbon dioxide laser vaporization. Br J Dermatol 136:356-359, 1997
145. Ratz JL: Carbon dioxide laser treatment of balanitis xerotica obliterans. J Am Acad Dermatol 10:925-928, 1984
146. Peterson CM, Lane JE, Ratz JL: Succcessful carbon dioxide laser therapy for refractory anogenital lichen sclerosus. Dermatol Surg 30:1148-1151, 2004
147. Nunez M et al: Pulsed dye laser treatment of teleangiectatic chronic erythema of lupus erythematosus. Arch Dermatol 132:354-355, 1996
148. Baniandres O et al: Treatment of lupus erythematosus with pulsed dye laser. Lasers Surg Med 32:327-330, 2003
149. Wolfe JT et al: Cutaneous lupus erythematosus following laser-induced thermal injury. Arch Dermatol,133;392-393, 1997
150. Karam F, Bauman T: Carbon dioxide laser treatment for chondrodermatitis nodularis chronica helicis. Ear Nose Throat J 67:757-763, 1988
151. Taylor MB: Chondrodermatitis nodularis chronica helicis. Successful treatment with the carbon dioxide laser. J Dermatol Surg Oncol 17:862-864, 1991
152. Békássy Z, Astedt B:Carbon dioxide laser vaporization of plaque psoriasis. Br J Dermatol 114:489-492, 1986
153. Tournas JA, Lowe NJ, Yamauchi PS: Laser and novel light source treatments for psoriasis. Lasers Surg Med 35:165-173, 2004
154. Zelickson BD et al: Clinical and histological evaluation of psoriatic plaques treated with a flashlamp pulsed dye laser. J Am Acad Dermatol 35:64-68, 1996
155. Hern S et al: Immunohistochemical evaluation of psoriatic plaques following selective photothermolysis of the superficial capillaries. Br J Dermatol 145:45-53, 2001
156. Mafong EA et al: Treatment of inverse psoriasis with the 308 nm excimer laser. Dermatol Surg 28:530-532, 2002
157. Taylor CR, Racette AL: A 308-nm excimer laser for the treatment of scalp psoriasis. Lasers Surg Med 34:136-140, 2004
158. Trehan M, Taylor CR: Medium-dose 308-nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol 47:701-708, 2002
159. Trehan M, Taylor CR: High-dose 308-nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol 46:732-737, 2002
160. Asawanonda P et al: 308-nm excimer laser for the treatment of psoriasis: A dose-response study. Arch Dermatol 136:619-624, 2000
161. Mavilia L et al: Wide-area 308-nm phototherapy with nonlaser light in the treatment of psoriasis: Results of a pilot study. Br J Dermatol 152:1376-1377, 2005
162. Köllner K et al: Comparison of the 308-nm excimer laser and a 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the treatment of psoriasis. Br J Dermatol 152:750-754, 2005
163. Kemény L et al: 308 nm excimer laser therapy for psoriasis. Arch Dermatol 137:95-96, 2001
164. Rodewald EJ et al: Follow-up survey of 308-nm laser treatment of psoriasis. Lasers Surg Med 31:202-206, 2002
165. Don PC, et al: Carbon dioxide laserabrasion: A new approach to management of familial chronic pemphigus (Hailey-Hailey disease). J Dermatol Surg Oncol 13:1187-1194, 1987
166. Christian MM, Moy RL: Treatment of Hailey-Hailey disease (or benign familial pemphigus) using short pulsed and short dwell time carbon dioxide lasers. Dermatol Surg 25:661-663, 1999
167. Haedersdal M, Togsverd-Bo K, Wulf HC: Evidence-based review of lasers, light sources and photodynamic therapy in the treatment of acne vulgaris. J Eur Acad Dermatol Venereol 22;267-278, 2008
168. Seaton ED et al: Pulsed-dye laser treatment for inflammatory acne vulgaris: randomised controlled trial. Lancet 362:1347-1352, 2003
169. Orringer JS et al: Treatment of acne vulgaris with a pulsed dye laser: A randomized controlled trial. JAMA 291:2834-2839, 2004
170. Mazer JM, Fayard V: Long-term results using the 1450 nm diode laser for the treatment of facial acne. Lasers Surg Med S17:37, 2005
171. Friedman PM et al: Treatment of inflammatory facial acne vulgaris with the 1450-nm diode laser: A pilot study. Dermatol Surg 30:147-151, 2004
172. Astner S, Anderson RR, Tsao SS: Clinical use of a 1450 nm diode laser for long-term acne control. Lasers Surg Med S17:36, 2005
173. Paithankar DYet al: Acne treatment with a 1450 nm wavelength laser and cryogen spray cooling. Lasers Surg Med 31:106-114, 2002
174. Tan SR, Tope WD: Pulsed dye laser treatment of rosacea improves erythema, symptomatology, and quality of life. J Am Acad Dermatol 51:592-599, 2004
175. Clark SM, Lanigan SW, Marks R: Laser treatment of erythema and telangiectasia associated with rosacea. Lasers Med Sci 17:26-33, 2002
176. Togsverd-Bo K et al: Short and limited effect of long-pulsed dye laser alone and in combination with photodynamic therapy for inflammatory rosacea. J Eur Acad Dermatol Venereol 23:200-201, 2009
177. Guerra L et al: Erbium:YAG laser and cultured epidermis in the surgical therapy of stable vitiligo. Arch Dermatol 139:1303-1310, 2003
178. Hadi SM, Spencer JM, Lebwohl M: The use of the 308-nm excimer laser for the treatment of vitiligo. Dermatol Surg 30:983-986, 2004
179. Hong S-B, Park H-H, Lee MH: Short-term effects of 308-nm xenon-chloride laser and narrow-band ultraviolet B in the treatment of vitiligo: A comparative study. J Korean Med Sci 20:273-278, 2004
180. Spencer JM, Nossa R, Ajmeri J: Treatment of vitiligo with the 308-nm excimer laser: A pilot study. J Am Acad Dermatol 46:727-731, 2002
181. Baltás E et al: Repigmentation of localized vitiligo with the xenon chloride laser. Br J Dermatol 144:1266-1267, 2001
182. Baltás E et al: Treatment of vitiligo with the 308-nm xenon chloride excimer laser. Arch Dermatol 138:1619-1620, 2002
183. Taneja A, Trehan M, Taylor CR: 308-nm excimer laser for the treatment of localized vitiligo. Int J Dermatol 42:658-662, 2003
184. Passeron T et al: Topical
tacrolimus and the 308-nm excimer laser. A synergistic combination for the treatment of vitiligo.
Arch Dermatol 140:1065-1069, 2004
185. Kawalek AZ, Spencer JM, Phelps RG: Combined excimer laser and topical
tacrolimus for the treatment of vitiligo: A pilot study.
Dermatol Surg 30:130-135, 2004
186. Gundogan C, Greve B, Raulin C: Treatment of alopecia areata with the 308-nm xenon chloride excimer laser: Case report of two successful treatments with the excimer laser. Lasers Surg Med 34:86-90, 2004
187. Zakaria W et al: 308-nm excimer laser therapy in alopecia areata. J Am Acad Dermatol 51:837-838, 2004
188. Chan HH et al: The use of pulsed dye laser for the prevention and treatment of hypertrophic scars in Chinese persons. Dermatol Surg 30:987-994, 2004
189. Nehal KS et al: Comparison of high-energy pulsed carbon dioxide laser resurfacing and dermabrasion in the revision of scars. Dermatol Surg 24:647-650, 1998
190. Jeong J-T, Park J-H, Kye J-C: Resurfacing of pitted facial acne scars using Er:YAG laser with ablation and coagulation mode. Aesthetic Plast Surg 27;130-134, 2003
191. Jeong J-T, Kye J-C: Resurfacing of pitted facial acne scars with a long-pulsed Er:YAG laser. Dermatol Surg 27:107-110, 2001
192. Tanzi EL, Alster T: Treatment of atrophic facial acne scars with a dual-mode Er:YAG laser. Dermatol Surg 28:551-555, 2002
193. Woo S-H, Park J-H, Kye J-C: Resurfacing of different types of facial acne scar with short-pulsed, variable-pulsed, and dual-mode Er:YAG laser. Dermatol Surg 30:488-493, 2004
194. Bellew SG, Lee CN, Weiss RA: Improvement of atrophic acne scars with a 1320 nm Nd:YAG laser: Retrospective study. Dermatol Surg 31:1218-1222, 2005
195. Sadick NS, Schecter AK: A preliminary study of utilization of the 1320-nm Nd:YAG laser for the treatment of acne scarring. Dermatol Surg 30:995-1000, 2004
196. Chan HH et al: Use of 1,320 nm Nd:YAG laser for wrinkle reduction and the treatment of atrophic acne scarring in Asians. Lasers Surg Med 34:98-103, 2004
197. Chua S-H et al: Nonablative 1450-nm diode laser in the treatment of facial atrophic acne scars in type IV to V asian skin: A prospective clinical study. Dermatol Surg 30:1287-1291, 2004
198. Yaghmai D et al: Comparison of a 1064 nm laser and a 1320 nm laser for the nonablative treatment of acne scars. Dermatol Surg 31:903-909, 2005
199. Weiss ET et al: Successful treatment of atrophic postoperative and traumatic scarring with carbon dioxide ablative fractional resurfacing: Quantitative volumetric scar improvement. Arch Dermatol 146:133-140, 2010
200. Tierney EP, Kouba DJ, Hanke CW: Review of fractional photothermolysis: Treatment indications and efficacy. Dermatol Surg 35:1445-1461, 2009
201. Alster TS: Manual of cutaneous laser techniques. Philadelphia, New York, Lippincott-Raven, 1997
202. Alster TS: Laser treatment of hypertrophic scars, keloids, and striae. Dermatol Clin 15:419-429, 1997
203. Jimenez GP et al: Treatment of striae rubra and striae alba with the 585-nm pulsed-dye laser. Dermatol Surg 29:362-365, 2003
204. Elsaie ML, Baumann LS, Elsaaiee LT: Striae distensae (stretch marks) and different modalities of therapy: An update. Dermatol Surg 35:563-573, 2009
205. Sellheyer K: Mechanisms of laser hair removal: could persistent photoepilation induce vitiligo or defects in wound repair? Dermatol Surg 33:1055-1065, 2007
206. DiBernardo BE et al: Laser hair removal: Where are we now? Plast Reconstr Surg 104:247-257, 1999
207. Tope WD, Hordinsky MK: A hair's breadth closer? Arch Dermatol 134;867-869, 1998
208. Ross EV et al: Theoretical considerations in laser hair removal. Dermatol Clin 17:333-355, 1999
209. Ross EV: Extended theory of selective photothermolysis: A new recipe for hair cooking? Lasers Surg Med 29:413-415, 1999
210. Rick K: Biophysikalische Grundlagen der Epilation. In: Photoepilation. Zur Praxis der Haarentfernung mittels Licht- und Lasersystemen, edited by G Kautz, K Rick, M Sandhofer. Darmstadt, Steinkopff, 2004, p. 50-52
211. Gold MH: Lasers and light sources for the removal of unwanted hair. Clin Dermatol 25:443-453, 2007
212. Tanzi EL, Alster TS: Long-pulsed 1064-nm Nd:YAG laser-assisted hair removal in all skin types. Dermatol Surg 30:13-17, 2004
213. Schroeter CA et al: Hair reduction using intense pulsed light source. Dermatol Surg 30:168-173, 2004
214. Sadick NS et al: Long-term photoepilation using a broad-spectrum intense pulsed light source. Arch Dermatol 136:1336-1340, 2000
215. Moreno-Arias GA, Castelo-Branco C, Ferrando J: Paradoxical effect after IPL photoepilation. Dermatol Surg 28:1013-1016, 2002
216. Alajlan A et al: Paradoxical hypertrichosis after laser epilation. J Am Acad Dermatol 53:85-88, 2005
217. Moreno-Arias GA et al: Side effects after IPL photoepilation. Dermatol Surg 28:1131-1134, 2002
218. Soden CE, Smith K, Skelton H: Histologic features seen in changing nevi after therapy with a 810 nm pulsed diode laser for hair removal in patients with dysplastic nevi. Int J Dermatol 40:500-504, 2001
219. Gottschaller C, Hohenleutner U: Laser- und Lichtepilation. In: Lasertherapie in der Dermatologie, edited by M Landthaler, U Hohenleutner. Heidelberg, Springer, 2006, p. 179-192.
220. Gansel RW: Photoepilation: State-of-the-art. Hautarzt 59:124-130, 2008
221. Sadighha A, Mohaghegh ZG: Meta-analysis of hair removal laser trials. Lasers Med Sci 24:21-25, 2009
222. Amin SP, Goldberg DJ: Clinical comparison of four hair removal lasers and light sources. J Cosmet Laser Ther 8:65-68, 2006
223. Raulin C et al: Benigne Lippenmelanose: Entfernung durch den gütegeschalteten Rubinlaser. Hautarzt 52:116-119, 2001
224. Akita H, Matsunaga K: Treatment of labial lentigines in atopic dermatitis with the frequency-doubled q-switched Nd:YAG laser. Arch Dermatol 136:936-937,
225. Todd MM et al: A comparison of 3 lasers and liquid nitrogen in the treatment of solar lentigines. A randomized, controlled, comparative trial. Arch Dermatol 136:841-846, 2000
226. Fitzpatrick RE, Goldman MP, Ruiz Esparza J: Clinical advantage of the CO2 laser superpulsed mode. Treatment of verruca vulgaris, seborrheic keratoses, lentigines, and actinic cheilitis. J Dermatol Surg Oncol 20:449-456, 1994
227. Alora MB, Arndt KA: Treament of a café-au-lait macule with the erbium:YAG laser. J Am Acad Dermatol 45:566-568, 2001
228. Moreno-Arias GA, Ferrando J: Intense pulsed light for melanocytic lesions. Dermatol Surg 27:397-400, 2001
229. Stratigos AJ, Dover JS, Arndt KA: Laser treatment of pigmented lesions—2000: How far have we gone? Arch Dermatol 136:915-921, 2000
230. Michel S et al: Der gütegeschaltete Rubinlaser in der Dermatologie—Anwendung und Indikation. Hautarzt 48:462-470, 1997
231. Goldberg DJ: Benign pigmented lesions of the skin. Treatment with the Q-switched ruby laser. J Dermatol Surg Oncol 19:376-379, 1993
232. Kono T et al: A retrospective study looking at the long-term complications of q-switched ruby laser in the treatment of nevus of Ota. Lasers Surg Med 29:156-159, 2001
233. Kono T et al: Use of Q-switched ruby laser in the treatment of nevus of ota in different age groups. Lasers Surg Med 32:391-395, 2003
234. Chan HH et al: A retrospective analysis of complications in the treatment of nevus of Ota with the q-switched alexandrite and q-switched Nd:YAG lasers. Dermatol Surg 26:1000-1006, 2000
235. Momosawa A et al: Combined therapy using Q-switched ruby laser and bleaching treatment with
tretinoin and
hydroquinone for acquired dermal melanocytosis.
Dermatol Surg 29;1001-1007, 2003
236. Kuchanak S, Leelaudomlipi P: Q-switched Nd:YAG laser treatment for acquired bilateral nevus of Ota-like maculae: A long-term follow-up. Lasers Surg Med 26:376-379, 2000
237. Lam AYM et al: A retrospective study on the efficacy and complications of Q-switched alexandrite laser in the treatment of acquired bilateral Nevus of Ota-like macules. Dermatol Surg 27:937-942, 2001
238. Dummer R, Kempf W, Burg G: Pseudo-melanoma after laser therapy. Dermatology 197:71-73, 1998
239. Johnsohn HA: Permanent removal of pigmentation from giant hairy naevi by dermabrasion. Br J Plast Surg 30:321-323, 1977
240. Rompel R, Möser M, Petres J: Dermabrasion of congenital nevocellular nevi: Experience in 215 patients. Dermatology 194:261-267, 1997
241. Goldberg DJ, Stampien T: Q-switched ruby laser treatment of congenital nevi. Arch Dermatol 131:621-623, 1995
242. Grevelink JM et al: Clinical and histological responses of congenital melanocytic nevi after single treatment with Q-switched lasers. Arch Dermatol 133:349-353, 1997
243. Rosenbach A, Williams CM, Alster TS: Comparison of the Q-switched Alexandrite (755 nm) and Q-switched Nd:YAG (1064 nm) lasers in the treatment of benign melanocytic nevi. Dermatol Surg 23:239-245, 1997
244. Vibhagool C, Byers HR, Grevelink JM: Treatment of small nevomelanocytic nevi with a Q-switched ruby laser. J Am Acad Dermatol 36:738-741, 1997
245. Bjerring P, Christiansen K: Intense pulsed light source for treatment of small melanocytic nevi and solar lentigines. J Cutan Laser Ther 2:177-181, 2000
246. Van Leeuwen RL et al: Modulation of alpha 4 beta 1 and alpha 5 beta 1 integrin expression: Heterogeneous effects of Q-switched ruby, Nd:YAG, and alexandrite lasers on melanoma cells in vitro. Lasers Surg Med 18:63-71, 1996
247. Chan HH et al: In vitro study examining the effect of sub-lethal QS 755 nm lasers on the expression of p16INK4a on melanoma cell lines. Lasers Surg Med 32:88-93, 2003
248. Sohn S, Kim S, Kang WH: Recurrent pigmented macules after q-switched alexandrite laser treatment of congenital melanocytic nevus. Dermatol Surg 30:898-907, 2004
249. Noordzij MJ et al: Ruby laser treatment of congenital melanocytic nevi: A review of the literature and report of our own experience. Plast Reconstr Surg 114:660-667, 2004
250. Kopera D, Hohenleutner U, Landthaler M: Melasma: Keine Indikation für den Rubinlaser. Z Hautkr 70:414-416, 1995
251. Taylor CR, Anderson RR: Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol 20:592-597, 1994
252. Angsuwarangsee S, Polnikorn N: Combined Ultrapulse CO2 laser and q-switched alexandrite laser compared with q-switched alexandrite laser alone for refractory melasma: Split-face design. Dermatol Surg 29:59-64, 2003
253. Wang C-C et al: Intense pulsed light for the treatment of refractory melasma in asian persons. Dermatol Surg 330:1196-1200, 2004
254. Karsai S, Raulin C: Fractional photothermolysis: A new option for treating melasma? Hautarzt 59:92-100, 2008
255. Pfirrmann G et al: Tattoo removal–State of the art. J Dtsch Dermatol Ges 5:889-897, 2007
256. Taylor CR et al: Light and electron microscopic analysis of tattoos treated by Q-switched ruby lasers. J Invest Dermatol 97:131-136, 1991
257. Ferguson JE et al: The Q-switched neodymium:YAG laser and tattoos: A microscopic analysis of laser-tattoo interaction. Br J Dermatol 137:405-410, 1997
258. Stafford TJ et al: Removal of colored tattoos with the Q-switched alexandrite laser. Plast Reconstr Surg 95:313-320, 1995
259. Fitzpatrick RE, Goldman MP: Tattoo removal using the alexandrite laser. Arch Dermatol 130:1508-1514, 1994
260. Dozier SE et al: The Q-switched Alexandrite laser's effects on tattoos in guinea pigs and harvested human skin. Dermatol Surg 21:237-240, 1995
261. Zelickson BD et al: Clinical, histologic, and ultrastructural evaluation of tattoos treated with three laser systems. Lasers Surg Med 15;364-372, 1994
262. Cesario-Kelly KM, Nelson JS: Q-switched laser treatment of tattoos. Lasers Med Sci 12:89-98, 1997
263. Ross EV et al: Comparison of responses of tattoos to to picosecond and nanosecond Q-switched Neodymium:YAG lasers. Arch Dermatol 134;167-171, 1998
264. Ferguson JE, August PJ: Evaluation of the Nd:YAG laser for treatment of amateur and professional tattoos. Br J Dermatol 135:586-591, 1996
265. Prinz BM et al: Efficacy of laser treatment of tattoos using lasers emitting wavelengths of 532 nm, 755 nm and 1064 nm. Br J Dermatol 150:245-251, 2004
266. Alster TS: Q-switched alexandrite laser treatment (755 nm) of professional and amateur tattoos. J Am Acad Dermatol 33:69-73, 1995
267. Adatto MA: Laser tattoo removal: Benefits and caveats. Med Laser Appl 19:175-185, 2005
268. Ross EV et al: Tattoo darkening and nonresponse after laser treatment. A possible role for titanium dioxide. Arch Dermatol 137:33-37, 2001
269. Anderson RR et al: Cosmetic tattoo ink darkening. A complication of Q-switched and pulsed laser treatment. Arch Dermatol 129:1010-1014, 1993
270. Rüdlinger R: Successful removal by ruby laser of darkened ink after ruby laser treatment of mismatched tattoos for acne scars. J Cutan Laser Ther 2:37-39, 2000
271. Bäumler W et al: Q-switch lasers and tattoo pigments—A chemical analysis of laser induced decomposition products. Lasers Surg Med 30:23, 2002
272. Vasold R et al: Tattoo pigments are cleaved by laser light - The chemical analysis in vitro provide evidence for hazardous compounds. Photochem Photobiol 80:185-190, 2004
273. Alster T, Gupta SN: Minocycline-induced hyperpigmentation treated with a 755-nm Q-switched Alexandrite laser. Dermatol Surg 30:1201-1204, 2004
274. Friedman IS, Shelton RM, Phelps RG: Minocycline-induced hyperpigmentation of the tongue: Successful treatment with the Q-switched ruby laser. Dermatol Surg 28:205-209, 2002
275. Karrer S et al: Amiodarone-induced pigmentation resolves after treatment with the Q-switched ruby laser. Arch Dermatol 135:251-253, 1999
276. Rüdlinger R: Ruby laser treatment for hyperpigmentation after cytotoxic therapy for AIDS-related Kaposi's sarcoma. Br J Dermatol 138:924-926, 1998
277. Yun PL, Arndt KA, Anderson RR: Q-switched laser-induced chrysiasis treated with long-pulsed laser. Arch Dermatol 138:1012-1014, 2002
278. Trotter Mj et al: Localized chrysiasis induced by laser therapy. Arch Dermatol 131:1411-1414, 1995